Lloyd Klickstein
Person
Guest on a previous podcast episode discussing short-term human studies on Rapamycin.
Mentioned in 5 videos
Videos Mentioning Lloyd Klickstein
175 - The biology of aging, rapamycin, and other interventions that target the aging process
Peter Attia MD
A researcher who, along with Joan Mannick, co-authored a 2014 paper on everolimus, influencing dosing strategies for rapamycin.
#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging
Peter Attia MD
Guest of the podcast, Chief Scientific Officer at Restore Bio, previously at Novartis and Brigham and Women's Hospital. Senior author on a pivotal 2014 paper on Rapamycin.
"Anti-Aging" Drugs — NAD, metformin, & rapamycin | The Peter Attia Drive Podcast (Ep 207, AMA 35)
Peter Attia MD
Mentioned as a past podcast guest discussing aging.
300-Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, & more
Peter Attia MD
Guest on a previous podcast episode discussing short-term human studies on Rapamycin.
Supplements for Longevity & Their Efficacy | Dr. Peter Attia
Andrew Huberman
Researcher who published a paper in 2014 demonstrating that everolimus enhanced immunity.